What is SLU-PP-332? It is an experimental ERR agonist small molecule studied in mice, not a peptide or approved supplement. Here's what research shows.
SLU-PP-332 is an experimental small molecule that activates estrogen-related receptors (ERRs), a family of proteins that regulate how cells generate and burn energy. It was developed by researchers at Saint Louis University — the SLU in its name — and gained attention after mouse studies showed increased running endurance and reduced body fat. SLU-PP-332 is not a peptide, is not an FDA-approved drug, and is not a legal dietary supplement for human use.
Is SLU-PP-332 a Peptide?
No. SLU-PP-332 is a synthetic small molecule, not a peptide. Peptides are short chains of amino acids; SLU-PP-332 is a single organic compound with a defined chemical structure.
Search results often label it a slu pp 332 peptide or a slu pp 332 research peptide, but that wording is a category error. The mix-up happens because the compound circulates in the same online communities that sell peptides like BPC-157 and MOTS-c.
The distinction is practical, not just semantic:
- Structure: small molecules are single chemical entities, while peptides are built from amino acid sequences.
- Stability: peptides are often degraded in the digestive tract, which is one reason many are injected.
- Regulation: neither class is approved for human consumption in the US, but they follow different manufacturing and labeling rules.
How SLU-PP-332 Works
SLU-PP-332 binds to and activates estrogen-related receptors, including ERRα, ERRβ, and ERRγ. These receptors function as transcription factors, meaning they turn specific genes on or off.
When ERR signaling is switched on, cells shift toward an energy profile that resembles the response to exercise:
- Increased mitochondrial biogenesis, or more mitochondria per cell
- Greater fatty acid oxidation, meaning more fat burned for fuel
- Higher oxidative capacity in skeletal muscle
Because it triggers some of the same gene programs as physical training, SLU-PP-332 is frequently described as an exercise mimetic. That label has only been tested in animals.
What Research Shows So Far
Nearly all evidence for SLU-PP-332 comes from cell cultures and rodent studies. No findings have been confirmed in people.
Published mouse research has reported the following:
- Treated mice ran substantially longer and farther on treadmills than untreated mice.
- Animals gained less fat and showed better insulin sensitivity without eating less food.
- In a heart-failure model, the compound improved cardiac function and exercise capacity.
- Some studies noted metabolic changes in the liver and kidneys beyond skeletal muscle.
These are the slu-pp-332 benefits most often cited online, but every one of them is a preclinical result in animals rather than proof of what the molecule does in humans.
What Is SLU-PP-332 Used For?
In practice, SLU-PP-332 is used as a laboratory research chemical. Scientists apply it to study ERR biology, mitochondrial function, and metabolic disease in cells and animal models.
It has no approved clinical use anywhere in the world. SLU-PP-332 is not prescribed for weight loss, athletic performance, diabetes, or any medical condition.
Human Trials and Safety Data
Anyone searching for slu-pp-332 human trials will find that none have been completed or published. There is no human safety data, no established toxicity profile, and no information on how the compound interacts with prescription medications.
Reported slu-pp-332 side effects are anecdotal and unverified, coming mostly from self-reported forum posts instead of clinical monitoring. Because ERR receptors sit close to hormone-related signaling pathways, there are theoretical concerns about tissue-specific effects that only formal trials could clarify.
Anyone considering an unapproved research compound should speak with a licensed healthcare professional first. This article is informational and is not medical advice.
Dosage, Forms, and Mouse-to-Human Translation
There is no established human slu-pp-332 dosage, and no research-backed amount for men, women, or any population. Doses used in mice are calculated per kilogram of body weight and cannot be converted into a safe human amount.
| Factor | Oral (capsules or powder) | Injection (subcutaneous) |
|---|---|---|
| Route used in published animal studies | Yes — oral dosing is the standard route | Not the primary route in the literature |
| Human pharmacokinetic data | None | None |
| Common form sold online | Capsules and loose powder | Less common |
| Main limitation | Unknown absorption and metabolism in people | Sterility, dosing errors, injection-site risk |
Researchers have noted that SLU-PP-332 has a short half-life and is rapidly metabolized, which is one reason newer analogs are being developed. Any discussion of slu-pp-332 oral vs injection compares two unapproved routes with zero human data behind them.
SLU-PP-332 vs MOTS-c
These two compounds are often discussed together because both are marketed around metabolism and exercise capacity. They belong to completely different chemical classes and work through different mechanisms.
| Feature | SLU-PP-332 | MOTS-c |
|---|---|---|
| Class | Synthetic small molecule (not a peptide) | Mitochondrial-derived peptide |
| Mechanism | ERR agonist that activates exercise-like gene programs | AMPK-related metabolic signaling |
| Typical research route | Oral in mice | Injectable in animal and early human studies |
| Human data | None published | Limited early human studies exist |
| Regulatory status | Research chemical only | Research chemical only |
A slu-pp-332 vs mots-c comparison ultimately shows two experimental compounds with different biology, and neither one is approved for human use.
Is SLU-PP-332 Sold as a Supplement?
You will see slu-pp-332 supplement listings online, but that label is misleading. In the United States, the compound is sold as a research chemical labeled not for human consumption, which means the FDA has not reviewed it for safety, purity, or dosage accuracy.
Product quality varies widely between vendors, and independent third-party testing is not guaranteed. Buying, importing, or reselling SLU-PP-332 for human use can also raise legal issues depending on the jurisdiction.
The Bottom Line
SLU-PP-332 is an experimental ERR agonist studied for exercise-mimicking metabolic effects. Every meaningful finding so far comes from cells and rodents, and no human trial results have been published.
The compound remains scientifically interesting and is one of the most discussed research molecules in metabolic research. It is also unapproved, unregulated, and untested in people, so any personal decision about it belongs with a qualified healthcare professional rather than an online vendor.
Frequently Asked Questions
Is SLU-PP-332 a peptide?
No. SLU-PP-332 is a synthetic small molecule that activates estrogen-related receptors (ERRs), not an amino acid chain. It is frequently mislabeled as a peptide because it is sold and discussed alongside peptides like MOTS-c and BPC-157.
What is SLU-PP-332 used for?
SLU-PP-332 is used as a laboratory research chemical to study ERR signaling, mitochondrial function, and metabolic disease in cells and animal models. It has no approved human use for weight loss, performance, or any medical condition.
Is SLU-PP-332 safe for humans?
There is no published human safety data for SLU-PP-332, and it has never been tested in completed human trials. It is not FDA-approved as a drug or dietary supplement, so anyone considering it should consult a licensed healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.